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Özet
Amaç: Bu çalışmada stabil KOAH’lı olgularda nötrofilik inflamasyon, hava 
yolu obstrüksiyonu ve serum interlökin-8(IL-8) düzeylerinin yüksek rezolüs-
yonlu bilgisayarlı tomografi ile ilişkisi araştırıldı. Gereç ve Yöntem: Şubat 
2005-Ocak 2006 tarihleri arasında 23 Evre I, 15 Evre II ve 12 Evre III-IV sta-
bil KOAH’lı hasta çalışmaya alındı. 10 sağlıklı sigara içmeyen, 20 sağlıklı si-
gara içen olgu çalışmaya kontrol grubu olarak dahil edildi. Solunum fonksi-
yon testleri yapıldı, balgam indüksiyonu ile eş zamanlı kan örneği alındı. Yük-
sek rezolüsyonlu bilgisayarlı tomografi çekildi ve görsel skorlama yöntemi ile 
değerlendirildi. Bulgular: Sigara içen gruplarda KOAH evresi arttıkça FEV1 
değeri düşmekte toplam akciğer skoru (TAS) artmaktaydı. KOAH evresi artı-
şı ile paralel olarak nötrofil sayısında artma, makrofaj sayısında ise azalma 
izlendi. KOAH evresi arttıkça IL-8 düzeyi artmakta idi. TAS ile FEV1 arasında 
ve nötrofil sayısı ile FEV1 arasında negatif korelasyon izlendi(p<0,001). Nöt-
rofil sayısı ile TAS ve IL-8 ile TAS arasında pozitif korelasyon izlenirken IL-8 
ile FEV1 arasında negatif korelasyon saptandı(p<0.001). Tartışma: KOAH’taki 
inflamasyonun derecesini ve ağırlığını belirlemede IL-8, indükte balgam ince-
lemesi; fonksiyonel ve anatomik değerlendirme ve evrelemede erken dönem-
de YRBT değerlendirmesinin kullanılabileceği sonucuna varıldı.
Anahtar Kelimeler
KOAH; YRBT; İndükte Balgam; IL-8
Abstract
Aim: In this study, the correlation between high-resolution computed tomog-
raphy (HRCT) and neutrophilic inflammation, air-way obstruction and serum 
IL-8 levels was examined in subjects with stable COPD. Material and Method: 
23 stage I, 15 Stage II and 12 Stage III–IV patients with COPD were included 
in the study. 10 healthy nonsmoking and 20 smoking participants were ad-
ditionally included to comprise the control group. Pulmonary function tests, 
sputum induction and blood collection were performed and HRCT assessed 
using the visual scoring method. Results: We observed that the forced expi-
ratory volume per second (FEV1) decreased and the total lung score (TLS) 
increased in smoking groups. An elevated number of neutrophils was ob-
served in parallel with increasing stages of COPD, whilst the number of mac-
rophages decreased in parallel. As the stage of COPD increased, the levels 
of IL-8 increased. A negative correlation between TLS and FEV1 and the 
number of neutrophils and FEV1 was observed among all subjects (p<0.001). 
A positive correlation was determined between the number of neutrophils 
and TLS, and IL-8 and TLS, whilst a negative correlation was observed be-
tween IL-8 and FEV1 (p<0.001). Discussion: When determining the degree 
and severity of inflammation in COPD, IL-8 analysis of induced sputum and 
both functional and anatomic assessment and staging assessment of HRCT 
in the early stage, can be effectively utilised.
Keywords
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Introduction
Chronic obstructive pulmonary disease (COPD) is a major cause 
of morbidity worldwide. Chronic airflow obstruction, the typical 
characteristic of COPD, is generally progressive and is associ-
ated with an abnormal inflammatory response of the lung to 
noxious particles, gases and in particular, cigarette smoke [1–3]. 
Numerous cells and mediators of inflammation exist in COPD 
and an elevation in neutrophils, macrophages and T lympho-
cytes is typically observed. 
Airway and alveolar epithelial cells are important sources of the 
inflammatory mediators. Pro-inflammatory mediators such as 
eicosanoids, cytokines and adhesion molecules are released fol-
lowing synthesis from the bronchial epithelial cells of healthy 
subjects inhaling noxious gasses [4]. Studies have known that 
the production of inflammatory mediators, particularly interleu-
kin-8 (IL-8), leukotriene B4 (LTB4) and tumor necrosis factor-
alpha (TNF) increase in COPD and that the neutrophils are the 
main source of these mediators. The production of these me-
diators has been utilised in the assessment of the severity of 
airway inflammation. In addition, induced sputum, a material 
obtained from the lower respiratory tract, can be used to assess 
the severity of airway inflammation [4; 5]. 
The  prevalence  and  anatomical  distribution  of  parenchymal 
damage can be easily assessed using high-resolution computed 
tomography (HRCT). Focal or diffuse air trapping can be deter-
mined following HRCT examination performed during expiration 
in subjects with airway obstruction. Consequently, inspiratory 
and expiratory HRCT plays an important role in the follow-up 
of the population at risk of developing obstructive disease [6]. 
 In the present study, the correlation between neutrophilic in-
flammation, airway obstruction and serum levels of IL-8 and 
HRCT findings was investigated in subjects with COPD. The cur-
rent study combined these parameters and assessed their use-
fulness in the role of early diagnosis.
Material and Method
Patients (inclusion and exclusion criteria)
Fifty patients receiving a diagnosis of COPD according to the 
Global Initiative for Chronic Obstructive Lung Disease (GOLD) 
Cough Consensus Panel Reports [1] in Atatürk Chest Diseases 
and Chest Surgery Education and Research Hospital were in-
cluded in the study. The participants were clinically stable dur-
ing the last 8 weeks and were using beta agonists or anticho-
linergics and did not use antibiotics or anti-inflammatory drugs 
such as inhaled/oral corticosteroids. Ten healthy nonsmoking 
and 20 smoking participants were also included to comprise the 
control group. The study was performed with the consent of the 
hospital ethics committee. 
Subjects were excluded from the study if they did not agree to 
participate or did not have a COPD diagnosis; they were dis-
qualified if they had atopy or were younger than 18 or older 
than 75 years of age; subjects with viral and bacterial infec-
tions, other inflammatory diseases, autoimmune diseases and 
malignancies that could affect IL-8 levels were also excluded.
Lung function tests, induced sputum and serum IL-8 measure-
ments.
The value of the forced expiratory volume per second (FEV1), 
the forced vital capacity (FVC), the ratio of residual volume to 
total lung capacity (RV/TLC), the diffusing capacity of the lung 
for carbon monoxide (DLCO) and the DLCO/alveoli ventilation 
(DLCO/VA) values were obtained to determine airflow impair-
ment using a Sensormedics V max 229 (Sensormedics, Yorba 
Linda, CA) series flow-sensitive spirometer in the Pulmonary 
Function Test Laboratory at our hospital. The diffusion capacity 
was measured using the single-breath method and the values 
were corrected according to age, height and weight. Patients 
were  classified  according  to  GOLD  2006  criteria  as  follows 
(with airflow limitation): FEV1/FVC < 70%; Stage I Mild COPD: 
FEV1 ≥ 80% predicted; Stage II Moderate COPD: 50% ≤ FEV1 < 
80% predicted, Stage III Severe COPD: 30% ≤ FEV1 < 50%; or 
Stage IV Very Severe COPD: FEV1 < 50% predicted + the pres-
ence of respiratory failure. 
Sputum induction was performed on the same day in the morn-
ing as previously described [7–9].
The sputum was separated macroscopically from saliva, and 
0.1 mg/ml (0.1%) dithiothreitol (DTT) was added to bind glyco-
protein fibres and unfold disulphide bonds, ensuring the gelous 
form of sputum achieving mucolysis and ensuring homogenisa-
tion. The sputum specimen for cell analysis was added in equal 
amounts. The sputum was incubated at 37˚C for 20 min, vor-
texed every 5 min and centrifuged at 2000 g for 10 min. The 
sediment was washed in D-PBS and the total number of cells 
counted using a Neubauer haemocytometer (Paul Marienfeld 
GmbH & Co., Königshofen, Germany). Then 1 × 10⁶ cells/ml were 
centrifuged at 450 g for 6 min, air-dried, stained with Wright’s 
stain and the cell distribution assessed (400 cells) [10; 11]. 
 Then 5 ml of blood was collected from the subjects simultane-
ously with the sputum induction. The samples were stored at 
–80˚C prior to the assessment of IL-8 serum levels using an 
ELISA kit (BioSource International Inc., Camarillo, CA, USA). Val-
ues of IL-8 were expressed in pg/ml.
 
HRCT
The inspiratory and expiratory HRCT sections were obtained 
and HRCT analyses performed on two occasions, following the 
performance of both deep inspirium and expirium. Each HRCT 
was scanned using a Pratico Spiral device (Hitachi, Tokyo, Ja-
pan) with a 10 mm table movement and 1 mm slice thickness 
(512 × 512 matrix size) without contrast material administra-
tion in the axial plane. HRCT Images, with a window width of 
1200 Hounsfield units (HU) and a window level of 700, were 
obtained. HRCT scans were acquired at three levels: 3 cm below 
the apex of the lung, at the hilus and 3 cm above the diaphragm. 
Six scan areas were used. The visual score method was utilised 
for the assessment of air trapping in the HRCT analyses. In 
this method, HRCT scans were estimated at each lung using a 
5-point scale: 0 (no air-trapping visible), 1 (1–25% of the cross-
sectional area of lung affected), 2 (2–50% affected), 3 (51–75% 
affected) and 4 (76–100% affected) [12]. 
The total lung score was equal to the sum of the total points 
of six sites of the cross-sectional areas. Visual analysis was 
performed without obtaining data from clinical situations, pul-
monary function test (PFT) values and lung graphy. As the cor-
relation between the observers and repeating observations are 
known in relation to the visual scoring of air-trapping, cross 
sections were assessed by two different radiologists. 
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Statistical analyses
Statistical analyses were performed using the SPSS 11.5 for 
Windows package programme (SPSS Inc., Chicago, IL, USA). An 
analysis of distribution of constant variance for normality was 
assessed using the Shapiro–Wilks’ test. Descriptive statistical 
analyses for gender were performed in the number and per-
centage of subjects, expressed as the mean ± SD for age and 
pack-years, and other clinical measurements were reported in 
the median (interquartile range). The significance of age with 
respect to age averages between the groups was examined us-
ing one-way ANOVA and Tukey’s post hoc test. The Kruskal–
Wallis test was used to identify the significance of differences 
between  median  values  of  clinical  measurements.  When  the 
comparison between groups indicated a significant result, non-
parametric multiple comparison tests were performed to iden-
tify the group responsible for the differences. Nominal variables 
were investigated with Pearson’s chi-square and Fisher’s exact 
tests. A p-value less than 0.05 was considered as statistically 
significant.
Results
Of the 80 subjects included in the study, 58 were male (72.5%) 
and 22 were female (27.5%). The male dominance in the group 
was considered to be due to male dominance in cigarette smok-
ing in our country. The age of the subjects ranged from 47 to 65 
years with a mean of 54.10 years. Ten of the subjects (12.5%) 
were  healthy  nonsmokers  (Group  1),  20  (25%)  were  healthy 
smokers (Group 2), 23 had (28.75%) Stage I COPD (Group 3), 
15 (18.75%) had Stage II COPD (Group 4) and 12 (15%) had 
Stage III–VI COPD (Group 5). The demographic data and clinical 
measurements of the subjects are shown tables 1 and 2. As the 
stage of COPD increased, the FEV1 values decreased in the cig-
arette smoking group. Stages III–IV displayed the lowest FEV1 
values (37.0%, p < 0.001). The total lung score (TLS) increased 
as the COPD stage increased. In Stages II and III–IV COPD TLS 
values were significantly higher (p < 0.001). No significant dif-
ferences  were  observed  between  two  groups  (p  >  0.05).  No 
significant differences were also observed between the total 
cell distributions among all groups (p > 0.05). Parallel to the in-
crease in COPD stage, an increase in the number of neutrophils 
was evident; however, the number of macrophages decreased 
as the stage of COPD increased. As the COPD stage increased, 
increased IL-8 levels were also detected. A strong negative cor-
relation was observed between TLS and FEV1 among all groups 
(p < 0.001) (Figure 1). A strong negative correlation between the 
number of neutrophils and FEV1 was also evident (p < 0.001) 
(Figure 2).
A positive correlation was determined between the number of 
neutrophils and TLS values (p < 0.001) (Figure 3). A positive cor-
relation between the IL-8 and TLS and a negative correlation 
between IL-8 and FEV1 were determined (p < 0.001) (figures 
4 and 5). 
Discussion
The GOLD 2006 criteria for COPD list two important new di-
mensions. First, COPD is a disease developing with systemic ef-
fects, and second, it is preventable and treatable. Since COPD is 
understood to be a global health problem causing an increased 
economic and social burden, investigations on the early diagno-
sis and treatment of COPD have accelerated [1].
The diagnosis of COPD relies on both functional and ra-
diographic criteria. Pulmonary function tests are easily 
applicable, noninvasive and cheap methods in the diag-
nosis, follow-up and the assessment of disability. How-
ever,  PFT  may  become  insufficient,  particularly  during 
the early stage of the disease, when the functional loss 
is insignificant. The most effective diagnostic method at 
this stage is to reveal air-trapping based on the perfor-
mance of quantitative HRCT measurements of lung tis-
sue density [13]. Lucidarme and colleagues deduced that 
air-trapping  suggests  airway 
obstruction  in  subjects  with 
clinically suspected COPD, but 
the  PFTs  are  normal  in  these 
subjects  and  the  air-trapping 
scores calculated on the expi-
ratory  HRCT  were  correlated 
with the degree of airway ob-
struction measured by PFT [6].
HRCT has succeeded in the de-
tection of morphologically low-
level  regions  of  emphysaema 
that cannot be detected by PFT 
and  chest  radiography,  with 
high sensitivity [13]. 
HRCT findings have been com-
pared  with  PFT  values  in  nu-
merous  studies.  A  significant 
Table 1. Demographic Datas and Correlations
Non-
smoker 
control 
Group 1 
(n=10)
Smoker 
control 
Group 2 
(n=20)
Stage 
I COPD 
Group 3 
(n=23)
Stage 
II COPD 
Group 4 
(n=15)
Stage III-
IV  COPD 
Group 5 
(n=12)
p
Age (years) 47.2±4.2 45.7±2.2 52.9±7.4 63.5±12.5 64.3±7.0 <0.001
Male gender  2 (%20) 13 (%65) 18 (%78.3) 13 (%86.7) 12 (%100) <0.001
Cigarette 
(Pack/years)
- 19.5±8.1 22.5±11.5 41.1±25.0 50.1±29.9 <0.001
Table 2. Clinical Measurements
Group 1 Group 2 Group 3 Group 4 Group 5 p
FEV1 102.5 (13.75) 96.0 (12.25) 86.0 (13.00) 65.0 (19.00) 37.0 (12.25) <0.001
FVC 104.0 (13.50) 93.0 (11.25) 96.0 (12.50) 83.0 (10.00) 66.5 (28.50) <0.001
FEV1/FVC 85.0 (4.50) 84.5 (4.00) 77.0 (16.50) 60.0 (10.00) 56.5 (14.75) <0.001
RV/TLC 38.5 (6.50) 31.0 (4.00) 41.0 (9.50) 48.0 (15.00) 56.0 (8.25) <0.001
DLCO 84.0 (5.75) 80.0 (7.50) 72.0 (9.50) 74.0 (18.00) 67.0 (10.50) <0.001
DLCO/VA 82.0 (6.25) 78.0 (9.75) 71.0 (9.00) 76.0 (18.00) 71.5 (14.00) <0.001
TLS 2.5 (1.50)  4.0 (1.75)  7.0 (6.00) 17.0 (9.00) 20.5 (5.75) <0.001
Total cell count (cells x10⁶) 2.0 (2.21) 4.4 (11.57) 2.9 (2.81) 2.8 (3.00) 5.2 (7.56) 0.039
Neutrophils 32.5 (23.50)  45.5 (31.75) 48.0 (31.50) 64.0 (13.00) 69.5 (20.00) <0.001
Macrophages 65.0 (20.00)  36.5 (30.50) 49.0 (28.00) 35.0 (19.00) 27.5 (19.50) <0.001
IL-8 117.5 (34.50) 265.0 (62.50) 710.0 (118.00) 992.0 (50.00) 1121.0 (201.00) <0.001
FEV1: Forced expiratory volume per second as liter
FVC: Forced vital capacity as liter
RV/TLC: The ratio of residual volume to total lung capacity
DLCO: Diffusing capacity of the lung for carbon monoxide as mL/seconds/mmHg
DLCO/VA: Diffusing capacity of the lung for carbon monoxide/ alveoli ventilation
TLS: Total lung score
IL-8: Interleukin-8
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correlation between decreased attenuation (one of the most 
common HRCT findings) and FEV1, FEF₂₅-₇₅ and RV has been 
reported [14]. Sakai et al [15] used the visual scoring method 
(depending  on  the  prevalence  and  severity  of  emphysaema) 
to determine a strong correlation between visual scoring val-
ues and pulmonary function test values. They determined the 
strongest correlation using the percentage of FEV1, FEV1/FVC 
consistent with other studies [16]. Additionally we detected a 
strong negative correlation between TLS and FEV1. 
Focal lucent areas at expiratory sections can be observed in 
some normal subjects whereby an increase in lung density nor-
mally observed in these regions cannot be observed due to air-
trapping. These images appear most typically in the superior 
segments of the lower lobes, anterior middle lobes or the lin-
gula. Additionally, technically uncontrollable factors such as pa-
tient mismatch and air pollution exist [17]. Özer and colleagues 
[18] reported that in patients with Behçet’s disease, a small 
airway disease at an early stage could be diagnosed through 
detecting air-trapping areas, whilst nonsmoking patients were 
asymptomatic or had normal PFT values. In the current study, 
TLS was found to be 2.5 (1.50) in nonsmoking subjects, which 
may be associated with these effects. We considered that, if 
these effects were excluded, the early detection of air-trapping 
on HRCT in nonsmoking and smoking subjects without COPD 
could be utilised for the treatment and prognosis prior to the 
initiation of the disease. 
 Induced sputum has been used in the diagnosis, treatment and 
follow-up of COPD treatment and asthma, since it was deter-
mined as useful in the investigation of airway inflammation. In 
the current study, we observed no side effects in patients during 
the test and no occurrences of a FEV1 decrease of more than 
20% during the follow-up of the pulmonary function test. In ad-
dition, no patients discontinued the test consistent with the low 
prevalence of side effects during sputum induction as previously 
reported. In this regard, Khajotia and coworkers [19] observed 
no side effects among 25 patients, but two patients were not 
able to co-operate completely with the process. In conclusion, 
sputum can be safely induced in patients with COPD. 
IL-8 is a chemoattractant and an activator of cytokines for neu-
trophils. IL-8 has been shown to be a useful marker when deter-
mining the severity of airway inflammation. In previous studies, 
the levels of IL-8 were reported to increase in the induced spu-
tum of the bronchoalveolar lavage fluid and in the serum [20]. 
According the format of the study we assessed serum IL-8 level 
but induced sputum IL-8 levels could be worked.
Perng and colleagues [21] determined that the number of spu-
tum neutrophils was negatively correlated with FEV1 values in 
subjects with stable COPD. IL-8 was determined to be correlat-
ed with the number of sputum neutrophils, and the numbers of 
sputum neutrophils and IL-8 were subsequently deduced to be 
associated with pulmonary functional impairment. In the pres-
ent study, an increase in the level of IL-8 parallel to the increase 
in number of neutrophils was detected and a strong negative 
correlation between the number of neutrophils and FEV1 values 
was observed. O’Donnell and colleagues [22] examined the re-
lationship between IL-8 and TLS and reported that TLS might 
Figure 1. Relationship between TLS and FEV1
Figure 4. Relationship between IL-8 and TLS Figure 5. Relationship between IL-8 and FEV1
Figure 2. Relationship between the number of neutro-
phils and FEV1
Figure 3. Relationship between the number of neu-
trophils and TLS
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increase in smoking subjects at early stages when airway ob-
struction does not develop. This study provided a positive corre-
lation between IL-8 and TLS. Consistently, in the current study, a 
positive correlation between IL-8 and TLS was observed. Paral-
lel to these results, a positive correlation between neutrophils 
and TLS and a negative correlation between FEV1 and IL-8 was 
determined. 
The dominant inflammatory cells in the airways of subjects with 
COPD are neutrophils. In studies performed by Peleman and co-
workers a high number of cells in the sputum were evident in 
COPD when compared with those of the healthy adult group. 
The  cell  distribution  in  the  induced  sputum  of  patients  was 
measured as 22.5% neutrophils and 74.0% macrophages in the 
control group and 74.9% neutrophils and 20.9% macrophages 
in the COPD group. These studies concluded that the presence 
of a high number of neutrophils was present in the sputum of 
patients of COPD, whilst a dominance of macrophages in the 
sputum of healthy adults occurs. Subsequently, it was deduced 
that the induced sputum was a reliable method for the detec-
tion of inflammatory cells in COPD [23]. Rutgers and coworkers 
[24] calculated the cell count to be 0.4–29.3 (mean 2.6) × 10⁶ 
in an induced sputum assessment performed on subjects with 
COPD. We observed that in the nonsmoking control group, of 
the total number of cells (2.5 × 10⁶), 33.4% were neutrophils 
whilst 63.2% were macrophages, but in the smoking control 
group, the total number of cells was 7.9 × 10⁶ and 48.7% were 
neutrophils and 43.8% macrophages. In subjects with COPD, we 
found 3.83 × 10⁶ cells of which 58.19% were neutrophils and 
35.77% macrophages. Thus, no significant differences among 
all subjects regarding the total number of cells were evident (p 
> 0.05).
In conclusion, the high levels of IL-8 in the serum of subjects 
with COPD are an indicator of inflammation in the lungs and 
a systemic influence, in addition to the related damage. Thus, 
if PFT values were normal in nonsmoking subjects or healthy 
smoking subjects with no COPD development, air-trapping re-
vealed by HRCT may be diagnosed early, dictating the treat-
ment and prognosis. Consequently, in determining the degree 
and severity of inflammation in COPD, the IL-8 analysis of in-
duced sputum, with functional and anatomic and staging as-
sessment of HRCT, can be used in the early stages of disease 
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